Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0001209191-22-057397

EVP - Business Operations acquired 1,524,947 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Masson Kristina EVP - Business Operations 2022-11-14 Grant or award +26,707 320,705 D
Masson Kristina EVP - Business Operations 2022-11-14 Grant or award +934,731 1,806,588 I
Masson Kristina EVP - Business Operations 2022-11-14 Grant or award +503,419 2,310,007 I
Masson Kristina EVP - Business Operations 2022-11-14 Grant or award +60,090 2,370,097 I
Derivatives
Masson Kristina EVP - Business Operations 2022-11-14 Grant or award · Stock Option (Right to Buy) +80,120 80,120 D
Masson Kristina EVP - Business Operations 2022-11-14 Grant or award · Stock Option (Right to Buy) +180,269 180,269 I
Loading xslF345X03/doc4.xml…